Literature DB >> 8390180

Design, synthesis, and conformation of superpotent and prolonged acting melanotropins.

V J Hruby1, S D Sharma, K Toth, J Y Jaw, F al-Obeidi, T K Sawyer, M E Hadley.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8390180     DOI： 10.1111/j.1749-6632.1993.tb19674.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  8 in total

1.  Structure-activity relationship study of collagen-derived anti-angiogenic biomimetic peptides.

Authors:  Elena V Rosca; Jacob E Koskimaki; Niranjan B Pandey; Amir P Tamiz; Aleksander S Popel
Journal:  Chem Biol Drug Des       Date:  2012-04-27       Impact factor: 2.817

Review 2.  Continuing pursuit for ideal systemic anticancer radiotherapeutics.

Authors:  Marlein Miranda Cona; Huaijun Wang; Junjie Li; Yuanbo Feng; Feng Chen; Peter de Witte; Alfons Verbruggen; Yicheng Ni
Journal:  Invest New Drugs       Date:  2011-10-18       Impact factor: 3.850

Review 3.  Mechanisms and modifications of naturally occurring host defense peptides for anti-HIV microbicide development.

Authors:  Colleen R Eade; Matthew P Wood; Alexander M Cole
Journal:  Curr HIV Res       Date:  2012-01-01       Impact factor: 1.581

4.  Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist.

Authors:  G V Skuladottir; L Jonsson; J O Skarphedinsson; F Mutulis; R Muceniece; A Raine; I Mutule; J Helgason; P Prusis; J E Wikberg; H B Schiöth
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

5.  Targeted melanoma imaging and therapy with radiolabeled alpha-melanocyte stimulating hormone peptide analogues.

Authors:  T Quinn; X Zhang; Y Miao
Journal:  G Ital Dermatol Venereol       Date:  2010-04       Impact factor: 2.011

6.  Design and characterization of alpha-melanotropin peptide analogs cyclized through rhenium and technetium metal coordination.

Authors:  M F Giblin; N Wang; T J Hoffman; S S Jurisson; T P Quinn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

7.  Interactions of the melanocortin-4 receptor with the peptide agonist NDP-MSH.

Authors:  Kathryn L Chapman; Gemma K Kinsella; Alan Cox; Dan Donnelly; John B C Findlay
Journal:  J Mol Biol       Date:  2010-06-19       Impact factor: 5.469

Review 8.  From Bioinactive ACTH to ACTH Antagonist: The Clinical Perspective.

Authors:  Chiraz Ghaddhab; Jean-Marc Vuissoz; Johnny Deladoëy
Journal:  Front Endocrinol (Lausanne)       Date:  2017-02-08       Impact factor: 5.555
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.